Pay in 4 interest-free payments of $5.96 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Looking Ahead While new partnerships and forthcoming price negotiations under the U.S
HL161, a novel anti-FcRn antibody as a new therapeutic option for pathogenic IgG-mediated autoimmune diseases [poster]
Targeting the NAD(+) salvage pathway suppresses APC mutation-driven colorectal [PMID: 32005247] Laboratory literature summary: Targeting the NAD(+) salvage pathway suppresses APC mutation-driven colorectal oncology research models growth and Wnt/-catenin
US$ 20.03
US$ 21.59
US$ 28.88
US$ 21.89
US$ 23.25
:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)
US$ 28.19
US$ 23.84
